insights_auto
Why is ARGX up 3.20%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
€741.60
arrow_upward
+3.20%(+23.00) 1D
Oct 14, 3:33:08 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€720.40
High
€742.00
Low
€714.40
Mkt. cap
46.45B
Avg. vol.
84.25K
Volume
23.09K
P/E ratio
31.42
52-wk high
€925.00
52-wk low
€568.40
EPS
€23.60
Shares outstanding
35.93M
No. of employees
2K
Open
€720.40
High
€742.00
Low
€714.40
Mkt. cap
46.45B
Avg. vol.
84.25K
Volume
23.09K
P/E ratio
31.42
52-wk high
€925.00
52-wk low
€568.40
EPS
€23.60
Shares outstanding
35.93M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
5 hours ago
Oppenheimer cuts target to USD 1,038 for Argenx stock
ad-hoc-news.de
·
8 hours ago
Argenx stock pre-market at EUR 718.20
ad-hoc-news.de
·
1 day ago
Baird cuts target for Argenx stock to USD 823.00
ad-hoc-news.de
·
2 days ago
Argenx halts UNITY study. Argenx stock trades 1.18 percent higher
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE